PARTICIPANTS WITH OBESITY AND KNEE OSTEOARTHRITIS

Clinical trials for PARTICIPANTS WITH OBESITY AND KNEE OSTEOARTHRITIS explained in plain language.

Never miss a new study

Get alerted when new PARTICIPANTS WITH OBESITY AND KNEE OSTEOARTHRITIS trials appear

Sign up with your email to follow new studies for PARTICIPANTS WITH OBESITY AND KNEE OSTEOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental drug aims to tackle both obesity and knee arthritis

Disease control Not yet recruiting

This phase 3 trial tests an injectable drug called ribupatide in people who have both obesity and knee osteoarthritis. The study measures whether ribupatide can reduce knee pain and stiffness, improve joint function, and help with weight loss over 68 weeks. Participants are rando…

Matched conditions: PARTICIPANTS WITH OBESITY AND KNEE OSTEOARTHRITIS

Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

PARTICIPANTS WITH OBESITY AND KNEE OSTEOARTHRITIS

Get alerted when new PARTICIPANTS WITH OBESITY AND KNEE OSTEOARTHRITIS trials appear

Experimental drug aims to tackle both obesity and knee arthritis